Hydroxyapatite in experimental laryngotracheal reconstruction

Laryngotracheal reconstruction remains a complex challenge in otolaryngology. Established approaches often rely on autogenous costal cartilage to expand the airway lumen. However, donor site morbidity limits this method. Prior research has shown that costal cartilage provides structural support but carries risks of complications. No prior work had resolved the trade-off between graft material and surgical outcomes. That uncertainty drove the search for alternatives. Porous hydroxyapatite emerged as a potential substitute due to its biocompatibility. This gap motivated the experimental comparison of hydroxyapatite with costal cartilage. The study aimed to assess whether hydroxyapatite could replicate the benefits of autogenous grafts while reducing donor site risks.

The study aimed to evaluate porous hydroxyapatite as an alternative to autogenous costal cartilage in laryngotracheal reconstruction. Researchers wanted to determine if hydroxyapatite could maintain structural integrity without donor site complications. The specific problem addressed was the risk of morbidity associated with costal cartilage grafts. The motivation stemmed from the need for less invasive reconstruction options. Experimental models were used to simulate clinical conditions. The study compared three groups: costal cartilage, hydroxyapatite with perichondrium, and hydroxyapatite alone. Outcomes were assessed at three months post-surgery. The goal was to identify whether hydroxyapatite could serve as a viable graft material.

The study involved 99 New Zealand rabbits randomly assigned to three groups. Each group received a different graft material: costal cartilage, hydroxyapatite with perichondrium, or hydroxyapatite alone. Animals were euthanized three months after surgery for evaluation. Clinical assessments were performed on 85 rabbits to monitor graft integration. Histological analysis was conducted on 81 specimens to evaluate tissue response. The presence of grafts was confirmed in 54 cases, with 27 rabbits showing no graft. Perichondrium grafts were used to cover hydroxyapatite in one group. Outcomes were compared across groups to determine material efficacy.

Clinically, no differences were observed between the three groups at three months. Histologically, costal cartilage grafts showed greater structural integrity than hydroxyapatite. The presence of a perichondrium graft did not significantly affect outcomes. Inflammation rates and graft viability were similar across all groups. A fibrous bridge was observed in 23 of 27 rabbits without a graft. This fibrous tissue maintained cricoid distraction in those cases. The study found no significant differences in epithelial layer coverage. The natural progression of the fibrous bridge remains unclear and requires further study.

The study suggests that hydroxyapatite may serve as a viable alternative to costal cartilage in experimental models. However, the authors emphasize that clinical application requires further investigation. The fibrous bridge observed in some rabbits raises questions about long-term stability. The authors propose that the natural course of this fibrous tissue must be documented. No significant differences were found in inflammation or graft viability between groups. The perichondrium graft did not improve outcomes in this study. The authors caution against assuming hydroxyapatite is superior without additional data. The findings support the need for follow-up studies on fibrous bridge development.